About this episode
Elliot Turner, Managing Partner and CIO of RGIA Investment Advisors, returns to The Business Brew for a great conversation. To start, Bill and Elliot discuss what Elliot learned from the period of 2021 to now. They then discuss some specific stock ideas, thoughts on portfolio management, and much more. We hope you enjoy.
Note: This episode was recorded on April 3, 2024. Bill owns a small position in Fevertree (established after recording) and a basket of positions in some smaller life science companies.
Detailed Show Notes:
3:00 - Learnings
10:30 - Prioritizing health to lead to success
14:00 - Was it an everything bubble?
22:15 - Fevertree discussion
37:40 - Thoughts on position sizing
44:30 - Incentives in finance papers
49:00 - A great NVDA story
55:00 - Is life sciences similar to tech after 2000
58:50 - The 3 forces that make life sciences and biotech interesting for humanity
1:08:00 - Is The Street focused on the wrong things?
1:16:20 - Maravai
1:25:00 - Thinking about patent cliffs
1:29:00 - High costs of failure and why that may be a good opportunity for existing suppliers
Get every episode summarized
Each time The Business Brew publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
